|
gptkbp:instanceOf
|
gptkb:clinical_trial
|
|
gptkbp:clinicalTrialPhase
|
NCT00433589
|
|
gptkbp:conditionStudied
|
gptkb:cancer
|
|
gptkbp:contrastsWith
|
clinical-pathological criteria
|
|
gptkbp:endDate
|
2016
|
|
gptkbp:endPoint
|
5-year distant metastasis-free survival
|
|
gptkbp:enrolledPatientsFrom
|
112 European cancer centers
|
|
gptkbp:foundIn
|
70-gene signature can identify breast cancer patients who may safely forgo chemotherapy
|
|
gptkbp:fullName
|
Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MINDACT trial
|
|
gptkbp:location
|
gptkb:Europe
|
|
gptkbp:participants
|
6693
|
|
gptkbp:principalInvestigator
|
Fatima Cardoso
|
|
gptkbp:publishedIn
|
gptkb:New_England_Journal_of_Medicine
|
|
gptkbp:result
|
Patients with high clinical risk but low genomic risk had excellent survival without chemotherapy
|
|
gptkbp:resultPublicationYear
|
2016
|
|
gptkbp:sponsor
|
European Organisation for Research and Treatment of Cancer
|
|
gptkbp:startYear
|
2007
|
|
gptkbp:trialPhase
|
Phase 3
|
|
gptkbp:usedTest
|
gptkb:MammaPrint
|
|
gptkbp:bfsParent
|
gptkb:Breast_International_Group
|
|
gptkbp:bfsLayer
|
5
|